Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES COMPANY

(PHAR)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Egyptian Exchange
09/12/2021 09/13/2021 09/14/2021 09/15/2021 09/16/2021 Date
46.63 46.63 46.69 46.3 46.3 Last
580 667 22194 63425 2110 Volume
0.00% 0.00% +0.13% -0.84% 0.00% Change
Estimated financial data (e)
Sales 2021 3 400 M 217 M 217 M
Net income 2021 578 M 36,9 M 36,9 M
Net Debt 2021 1 090 M 69,6 M 69,6 M
P/E ratio 2021 7,80x
Yield 2021 7,57%
Sales 2022 3 900 M 249 M 249 M
Net income 2022 690 M 44,0 M 44,0 M
Net Debt 2022 1 454 M 92,8 M 92,8 M
P/E ratio 2022 6,72x
Yield 2022 8,86%
Capitalization 4 592 M 292 M 293 M
EV / Sales 2021 1,67x
EV / Sales 2022 1,55x
Nbr of Employees -
Free-Float 44,7%
More Financials
Company
Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) is an Egypt-based public shareholding company that operates in the pharmaceuticals industry. The Company is a manufacturer and exporter of pharmaceuticals, and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones. The Company produces dosage forms, such as... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Ratings of Egyptian International Pharmaceutical Industries Company
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES COMPANY
08/11Egyptian International Pharmaceutical Industries Company Reports Earnings Res..
CI
05/11Egyptian International Pharmaceutical Industries Company Reports Earnings Res..
CI
03/28Egyptian International Pharmaceutical Industries Company Appoints Ahmed Saeed..
CI
03/28Egyptian International Pharmaceutical Industries Approves Cash Dividend for 2..
CI
02/25Egyptian International Pharmaceutical Industries Company Reports Earnings Res..
CI
2020Medical Union Pharmaceuticals Company announced that it expects to receive EG..
CI
2020Egyptian International Pharmaceutical Industries Company Declares Cash Divide..
CI
2020Egyptian International Pharmaceutical Industries Company announces an Equity ..
CI
2020Egyptian International Pharmaceutical Industries Company authorizes a Buyback..
CI
2019Egyptian International Pharmaceutical Industries Company completed the acquis..
CI
2019Egyptian International Pharmaceuticals Reports Consolidated Earnings Results ..
CI
2019Egyptian International Pharmaceuticals Reports Standalone Earnings Results fo..
CI
2019Egyptian International Pharmaceutical Industries Company agreed to acquire 9...
CI
2019Egyptian International Pharmaceutical Industries Company Reports Consolidated..
CI
2019Egyptian International Pharmaceutical Industries Company Declares Cash Divide..
CI
More news
News in other languages on EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES COMPANY

- No features available -

More news
Chart EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES COMPANY
Duration : Period :
Egyptian International Pharmaceutical Industries Company Technical Analysis Chart | PHAR | EGS38081C013 | MarketScreener
Technical analysis trends EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES COMPANY
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 46,30 EGP
Average target price 64,98 EGP
Spread / Average Target 40,3%
EPS Revisions
Managers and Directors
Ahmed Said Mohammed Kilany El-Bucheiry Chairman & Managing Director
Mohamed Hassan Ibrahim Chief Financial Officer
Mohamed Hasanin Manager-Information Technology
Hamdi Mahmoud El-Sayed Non-Executive Director
Maher Mohammad Ali Al-Domiaty Non-Executive Director